Show simple item record

dc.creatorHopkins, Christina R.
dc.creatorRen, Vicky
dc.creatorGrover, Raminder
dc.creatorCockerell, Clay
dc.creatorHsu, Sylvia
dc.date.accessioned2023-12-21T19:36:58Z
dc.date.available2023-12-21T19:36:58Z
dc.date.issued2022-02-14
dc.identifier.citationHopkins C R, Ren V, Grover R, et al. (February 14, 2022) When Bullous Pemphigoid Is Not Bullous Pemphigoid: The Importance of Going Beyond Direct Immunofluorescence. Cureus 14(2): e22201. doi:10.7759/cureus.22201
dc.identifier.issn2168-8184
dc.identifier.urihttp://hdl.handle.net/20.500.12613/9365
dc.description.abstractBullous pemphigoid (BP) is the most common autoimmune bullous disease, but rarer forms of pemphigoid may appear identical to BP on routine histopathology and direct immunofluorescence (DIF). Here, we present the case of a 60-year-old man, who was initially thought to have BP, with supportive findings on routine histopathology and DIF. However, prominent oral involvement and cutaneous lesions refractory to conventional treatment suggested an alternate diagnosis. Further workup was performed, including indirect immunofluorescence (IIF) on salt-split skin, which showed binding of antibodies to the dermal floor rather than to the blister roof, and enzyme-linked immunosorbent assay for pemphigus and pemphigoid antibodies. With these additional tests, we concluded that the patient does not have BP but rather anti-p200 pemphigoid, anti-p105 pemphigoid, or a yet undiscovered form of pemphigoid. We reached a presumptive diagnosis of anti-p200 pemphigoid, as it is the most common pemphigoid with serum antibodies to the dermal floor of human salt-split skin by IIF. This case demonstrates that suspicion for other autoimmune bullous diseases in cases of treatment-refractory and clinically aberrant BP is essential. A limited workup may lead to a missed diagnosis and ultimately less efficient disease management.
dc.format.extent5 pages
dc.languageEnglish
dc.language.isoeng
dc.relation.ispartofFaculty/ Researcher Works
dc.relation.haspartCureus, Vol. 14
dc.relation.isreferencedbySpringer
dc.rightsAttribution CC BY
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectSalt-split skin
dc.subjectIndirect immunofluorescence
dc.subjectDirect immunofluorescence
dc.subjectAutoimmune bullous disease
dc.subjectBullous pemphigoid
dc.subjectLaminin gamma-1
dc.subjectAnti-p105 pemphigoid
dc.subjectAnti-p200 pemphigoid
dc.titleWhen Bullous Pemphigoid Is Not Bullous Pemphigoid: The Importance of Going Beyond Direct Immunofluorescence
dc.typeText
dc.type.genreJournal article
dc.contributor.groupTemple University. Hospital
dc.description.departmentDermatology
dc.relation.doihttp://dx.doi.org/10.7759/cureus.22201
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.description.schoolcollegeLewis Katz School of Medicine
dc.creator.orcidHsu|0000-0001-7885-3730
dc.temple.creatorHsu, Sylvia
refterms.dateFOA2023-12-21T19:36:58Z


Files in this item

Thumbnail
Name:
HsuEtAl-JournalArticle-2022-02.pdf
Size:
1.076Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution CC BY
Except where otherwise noted, this item's license is described as Attribution CC BY